期刊文献+

乳腺癌卵巢转移17例报告 被引量:5

Report of 17 Patients with Ovary Metastases from Breast Cancer
下载PDF
导出
摘要 目的 探讨有卵巢转移的乳腺癌患者的临床病程特点。方法 回顾性分析 195 8年~ 1990年 17例患者的临床资料。结果 从开始治疗原发肿瘤到卵巢转移确诊的中位生存期为 17个月 ;卵巢转移确诊后中位生存期为 16个月 ;1、3、5年的生存率分别为 68.8%、2 3 .0 %和 5 .9%。原发肿瘤诊断时的年龄、腋淋巴结状态、无瘤生存时间的长短及是否同时有卵巢外其他部位的转移等因素均影响患者的预后。结论 有卵巢转移的乳腺癌患者的预后很差 ,综合治疗可能是其最佳的治疗方法。 Objective To explore the clinical characteristics,treatment and prognostic factors of breast cancer patients with ovary metastases.Methods Clinical data of 17 cases between 1958~1990 were reviewed retrospectively.Results The median time from initial treatment of primary tumor to ovary metastases was 17 months,the median survival time after ovary metastases was 16 months.The 1 ,3 and 5 year survival rate was 68.8%,23.0% and 5.95%,respectively.The age and axillary nodal status at diagnosis of the primary tumor,the length of disease free interval,ovary metastases with concomitant involvement of extra ovary may provide information for predicting survival.Conclusion The prognosis of ovary metastases from breast cancer is rather poor.Multimodality treatment seems to be a better choice of approach.
出处 《实用癌症杂志》 2000年第4期418-419,共2页 The Practical Journal of Cancer
关键词 卵巢肿瘤 乳腺癌 肿瘤转移 治疗 病例报告 Ovary neoplasm Secondary Breast neoplasm Therapy survival rate
  • 相关文献

参考文献5

  • 1Petru E,Pickel H,Heydarfadai M,et al.Nongenital cancers metastatic to the ovary〔J〕[].Gynecologic Oncology.1992
  • 2Possinger K,Wilmanns W.Palliative therapiefuhrung zur hemmung der tumor progression bei patientinnen mit tastasierten mammakmearzinomen〔J〕[].The Internist.1994
  • 3Ayhan A,Tuncer ZS,Bukwlmez O.Malignant tumors metastatic to the ovaries〔J〕[].Jour of Surg Oncol.1995
  • 4Gagnon Y,Tetu B.Ovarian metastases of breast carcinoma.A clinicopathologic study of 59 cases〔J〕[].Cancer.1989
  • 5Clark GM,Sledge GW,Osborne J,et al.Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients〔J〕[].Journal of Clinical Oncology.1987

同被引文献15

  • 1祁向东,刘金龙,袁景伦,陈国玉.胃癌转移卵巢的临床诊断与治疗[J].南京医科大学学报(自然科学版),2006,26(3):218-219. 被引量:5
  • 2Stanojevic Z, Dordevic B, Zivanovic D. Influence of the primary malignant tumor site on the incidence and features of metastatic ovarian tumors. Vojnosanit Pregl,2007 ,64 :691- 696.
  • 3Ho L, Quan V, Henderson R. Bilateral ovarian metastases from breast carcinoma on FDG PET-CT. Clin Nucl Med, 2007,32: 935 -936.
  • 4Perrotin F, Marret H, Bouquin R, et al. Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer. Gynecol Obstet Fertil,2001,29 :308-315.
  • 5Tserkezoglou A, Kontou S, Hadjieleftheriou G, et al. Primary and metastatic ovarian cancer in patients with prior breast carcinoma; preoperative markers and treatment results. Anticancer Res, 2006,26:2339-2344.
  • 6连利娟,林巧稚.妇科肿瘤学[M].3版.北京:人民卫生出版社,2000:213-246.
  • 7Tserkezoglou A, Kontou S, Hadjieleftheriou G, et ai Primary andmetastatic ovarian cancer in patients with prior breast carcinoma.Pre-operative markers and treatment results[J]. Anticancer Res,2006,26(3B):2339-44.
  • 8Lehr HA, Folpe A, Yaziji H, et al. Cytokeratin 8 immunostainingpattern and E-cadherin expression distinguish lobular from ductalbreast carcinoma[J]. Am J Clin Pathol, 2000, 114(2):190-6.
  • 9Li Cl, Anderson BO, Daling JR, et al. Trends in incidence ratesof invasive lobular and ductal breast carcinoma[J]. JAMA, 2003,289(11):1421-4.
  • 10Arpino G, Bardou VJ, Clark GM, et al.Infiltrating lobularcarcinoma of the breast: tumor characteristics and clinicaloutcome[J].Breast Cancer Res, 2004,6(3):R149-56.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部